Skip to main navigation Skip to search Skip to main content

Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial

  • Scott D. Solomon
  • , Adel R. Rizkala
  • , Jianjian Gong
  • , Wenyan Wang
  • , Inder S. Anand
  • , Junbo Ge
  • , Carolyn S.P. Lam
  • , Aldo P. Maggioni
  • , Felipe Martinez
  • , Milton Packer
  • , Marc A. Pfeffer
  • , Burkert Pieske
  • , Margaret M. Redfield
  • , Jean L. Rouleau
  • , Dirk J. Van Veldhuisen
  • , Faiez Zannad
  • , Michael R. Zile
  • , Akshay S. Desai
  • , Victor C. Shi
  • , Martin P. Lefkowitz
    • John J.V. McMurray

Research output: Contribution to journal › Review article › peer-review

281   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science